Literature DB >> 7954258

Prediction of breast cancer malignancy using an artificial neural network.

C E Floyd1, J Y Lo, A J Yun, D C Sullivan, P J Kornguth.   

Abstract

BACKGROUND: An artificial neural network (ANN) was developed to predict breast cancer from mammographic findings. This network was evaluated in a retrospective study.
METHODS: For a set of patients who were scheduled for biopsy, radiologists interpreted the mammograms and provided data on eight mammographic findings as part of the standard mammographic workup. These findings were encoded as features for an ANN. Results of biopsies were taken as truth in the diagnosis of malignancy. The ANN was trained and evaluated using a jackknife sampling on a set of 260 patient records. Performance of the network was evaluated in terms of sensitivity and specificity over a range of decision thresholds and was expressed as a receiver operating characteristic curve.
RESULTS: The ANN performed more accurately than the radiologists (P < 0.08) with a relative sensitivity of 1.0 and specificity of 0.59.
CONCLUSIONS: An ANN can be trained to predict malignancy from mammographic findings with a high degree of accuracy.

Entities:  

Mesh:

Year:  1994        PMID: 7954258     DOI: 10.1002/1097-0142(19941201)74:11<2944::aid-cncr2820741109>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  New statistical learning theory paradigms adapted to breast cancer diagnosis/classification using image and non-image clinical data.

Authors:  Walker H Land; John J Heine; Tom Raway; Alda Mizaku; Nataliya Kovalchuk; Jack Y Yang; Mary Qu Yang
Journal:  Int J Funct Inform Personal Med       Date:  2008-01

2.  An evolutionary hybrid cellular automaton model of solid tumour growth.

Authors:  P Gerlee; A R A Anderson
Journal:  J Theor Biol       Date:  2007-02-12       Impact factor: 2.691

Review 3.  Anniversary paper: History and status of CAD and quantitative image analysis: the role of Medical Physics and AAPM.

Authors:  Maryellen L Giger; Heang-Ping Chan; John Boone
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

4.  A neural network application to classification of health status of HIV/AIDS patients.

Authors:  N K Kwak; C Lee
Journal:  J Med Syst       Date:  1997-04       Impact factor: 4.460

5.  Sparseness of the trabecular pattern on dental radiographs: visual assessment compared with semi-automated measurements.

Authors:  W G M Geraets; C Lindh; H Verheij
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

6.  Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks.

Authors:  Kenneth Hoyt; Jason M Warram; Heidi Umphrey; Lin Belt; Mark E Lockhart; Michelle L Robbin; Kurt R Zinn
Journal:  J Ultrasound Med       Date:  2010-04       Impact factor: 2.153

7.  Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration.

Authors:  Turgay Ayer; Oguzhan Alagoz; Jagpreet Chhatwal; Jude W Shavlik; Charles E Kahn; Elizabeth S Burnside
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

8.  Variations of glutamate concentration within synaptic cleft in the presence of electromagnetic fields: an artificial neural networks study.

Authors:  Neda Masoudian; Gholam Hossein Riazi; Ali Afrasiabi; Seyed Mohamad Sadegh Modaresi; Ali Dadras; Shahrbanoo Rafiei; Meysam Yazdankhah; Atiye Lyaghi; Mostafa Jarah; Shahin Ahmadian; Hossein Seidkhani
Journal:  Neurochem Res       Date:  2015-01-13       Impact factor: 3.996

9.  Modelling evolutionary cell behaviour using neural networks: application to tumour growth.

Authors:  P Gerlee; A R A Anderson
Journal:  Biosystems       Date:  2008-11-05       Impact factor: 1.973

Review 10.  Bridging scales in cancer progression: mapping genotype to phenotype using neural networks.

Authors:  Philip Gerlee; Eunjung Kim; Alexander R A Anderson
Journal:  Semin Cancer Biol       Date:  2014-05-12       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.